Bibliographical noteFunding Information:
Funding. E.R.S. has funding from the National Institutes of Health National Institute of Neurological Disorders and Stroke (R01 NS035192) and JDRF (3-SRA-2017-483-S-B). Duality of Interest. E.R.S. has served as an advisor/consultant for Sanofi, Zucara, MannKind, and Eli Lilly. Her university has received grant funding from Eli Lilly for an investigator-initiated project developed and implemented by E.R.S. No other potential conflicts of interest relevant to this article were reported.
PubMed: MeSH publication types
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't